Shareholder Ma Liping of Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SH) intends to reduce their stake by no more than 1%.

19:16 18/03/2026

Aibo Medical (688050.SH) announced that shareholder Mr. Mao Liping plans to reduce his holdings of the company's shares by no more than 1% of the total share capital, totaling no more than 1.934 million shares, through block trades.

Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SH) announced that shareholder Mr. Mao Liping plans to reduce his total holdings of the company's shares by no more than 1% of the total share capital, which is equivalent to a total of 1,934,000 shares, through block trades.

JACOBIO-B (01167) spent HKD 998,000 to repurchase 144,000 shares on March 18th.

PROSPEROUSPRINT (08385): Liquidation application has been withdrawn.

LUZHU BIOTECH-B (02480) announced that its net loss for 2025 is approximately 150 million yuan, a decrease of 10.6% compared to the previous year.

JACOBIO-B (01167) spent HKD 998,000 to repurchase 144,000 shares on March 18th.

PROSPEROUSPRINT (08385): Liquidation application has been withdrawn.

LUZHU BIOTECH-B (02480) announced that its net loss for 2025 is approximately 150 million yuan, a decrease of 10.6% compared to the previous year.